GLPwatch
Cagrilintide vs Tirzepatide
Molecule comparison
Last updated 2026-05-28 15:46 UTCCagrilintide is an experimental long-acting amylin drug still in development, with no approved treatments yet. Tirzepatide, sold as Mounjaro or Zepbound, is an FDA-approved dual-action drug for type 2 diabetes, obesity, and obstructive sleep apnea, taken by injection.
AI summary of the sources below.
| Cagrilintide | Tirzepatide | |
|---|---|---|
| Mechanism | Long-acting amylin analogue | GIP and GLP-1 receptor dual agonist |
| Status | Pipeline | Approved |
| Branded products | — | mounjaro, zepbound |
Compare full details on the Cagrilintide and Tirzepatide pages.